In the context of CML, the main driver mutation is a t(9;22)(q34;q11) balanced reciprocal translocation event, which results in the formation of the Philadelphia chromosome characterized by a BCR:ABL1 fusion gene[51]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.